Idorsia Pharmaceuticals Ltd.

Idorsia Pharmaceuticals Ltd. is a Swiss biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines across multiple therapeutic areas, including CNS, cardiovascular, and immunological disorders. The company is committed to scientific innovation and improving patient outcomes worldwide.